Signpost gets Bengaluru metro advertising deal of up to INR7B
Signpost India shares surged by 10.4% on Monday, reaching an intra-day high of ₹311.9 per share on the BSE, following the company's announcement of securing exclusive advertising rights for all 67 metro stations operated by the Bengaluru Metro Rail Corporation Limited (BMRCL) [1].
The deal, which spans a tenure of nine years till 2034, is expected to generate revenue potential of ₹600 crore to ₹700 crore (excluding GST) [1]. This significant contract positions Signpost India as a key player in the rapidly evolving digital out-of-home (DOOH) advertising sector, known for delivering strong returns in the global media market.
The company's growth strategy aligns with expanding its presence across major urban transit ecosystems, leveraging the high-footfall environment of metro stations in Bengaluru. The cumulative display space—both static and digital—aggregates to over 95,000 square feet, offering substantial advertising opportunities [1].
Signpost India's stock has shown resilience, gaining 15.5% over the past year compared to the Sensex's decline of 0.47% [1]. This upward trajectory underscores investor confidence in the company's growth prospects and strategic positioning in the OOH advertising industry.
The deal with BMRCL, a Special Purpose Vehicle formed as a joint venture between the Government of Karnataka and the Government of India, further solidifies Signpost India's position in the market. BMRCL's metro project, popularly known as 'Namma Metro', offers a strategic display space across key metro stations in Bengaluru [1].
This development is aligned with Signpost India's innovation-driven approach, setting new benchmarks in the DOOH advertising sector with initiatives like India’s first and largest main street DOOH billboards and the world’s largest digital bus queue shelter [1].
References:
[1] https://www.business-standard.com/markets/news/smallcap-stock-jumps-10-percent-on-securing-bengaluru-metro-advertising-rights-125082500273_1.html
Comments
No comments yet